These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 36458906)
1. The Complex Association of Daily Opioid Dose with Visits for Pain in Sickle Cell Disease: Tolerance or Treatment-Refractory Pain? Prince EJ; Pecker LH; Lanzkron S; Carroll CP Pain Med; 2023 Jun; 24(6):703-712. PubMed ID: 36458906 [TBL] [Abstract][Full Text] [Related]
3. Opioid treatment for acute and chronic pain in patients with sickle cell disease. Carroll CP Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753 [TBL] [Abstract][Full Text] [Related]
4. Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: The role of non-hematologic characteristics and baseline chronic opioid dose. Carroll CP; Cichowitz C; Yu T; Olagbaju YO; Nelson JA; Campbell T; Lanzkron S Am J Hematol; 2018 Sep; 93(9):1127-1135. PubMed ID: 30035821 [TBL] [Abstract][Full Text] [Related]
5. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit. Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541 [TBL] [Abstract][Full Text] [Related]
6. The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain. Muslu CS; Kopetsky M; Nimmer M; Visotcky A; Fraser R; Brousseau DC Pediatr Blood Cancer; 2020 Sep; 67(9):e28268. PubMed ID: 32614150 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015. Wilson TT; Chou SC; Becker S; Schuur JD; Beaudoin F Am J Emerg Med; 2021 Dec; 50():597-601. PubMed ID: 34592567 [TBL] [Abstract][Full Text] [Related]
8. Outpatient management of sickle cell pain with chronic opioid pharmacotherapy. Shaiova L; Wallenstein D J Natl Med Assoc; 2004 Jul; 96(7):984-6. PubMed ID: 15253332 [TBL] [Abstract][Full Text] [Related]
9. Pain management in adults with sickle cell disease in a medical center emergency department. Solomon LR J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290 [TBL] [Abstract][Full Text] [Related]
11. Opioid prescription practices at discharge and 30-day returns in children with sickle cell disease and pain. Okorji LM; Muntz DS; Liem RI Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27800652 [TBL] [Abstract][Full Text] [Related]
12. Opioid utilization patterns in United States individuals with sickle cell disease. Ballas SK; Kanter J; Agodoa I; Howard R; Wade S; Noxon V; Dampier C Am J Hematol; 2018 Oct; 93(10):E345-E347. PubMed ID: 30051929 [No Abstract] [Full Text] [Related]
13. Association of Refractory Pain in the Acute Phase After Subarachnoid Hemorrhage With Continued Outpatient Opioid Use. Jaffa MN; Podell JE; Smith MC; Foroutan A; Kardon A; Chang WW; Motta M; Parikh GY; Sheth KN; Badjatia N; Armahizer MJ; Simard JM; Morris NA Neurology; 2021 May; 96(19):e2355-e2362. PubMed ID: 33766993 [TBL] [Abstract][Full Text] [Related]
14. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management. Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779 [TBL] [Abstract][Full Text] [Related]
15. A Multiyear Cross-sectional Study of Guideline Adherence for the Timeliness of Opioid Administration in Children With Sickle Cell Pain Crisis. Brousseau DC; Alpern ER; Chamberlain JM; Ellison AM; Bajaj L; Cohen DM; Hariharan S; Cook LJ; Harding M; Panepinto J; Ann Emerg Med; 2020 Sep; 76(3S):S6-S11. PubMed ID: 32928464 [TBL] [Abstract][Full Text] [Related]
17. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease. Givens M; Rutherford C; Joshi G; Delaney K J Emerg Med; 2007 Apr; 32(3):239-43. PubMed ID: 17394984 [TBL] [Abstract][Full Text] [Related]
18. Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients? Nobrega R; Carullo V; Thein SL; Quezado ZMN Expert Rev Hematol; 2022 Oct; 15(10):887-891. PubMed ID: 36191299 [TBL] [Abstract][Full Text] [Related]
19. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial. Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277 [TBL] [Abstract][Full Text] [Related]
20. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis. Payne J; Aban I; Hilliard LM; Madison J; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD Pediatr Blood Cancer; 2018 Dec; 65(12):e27420. PubMed ID: 30151977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]